Anlotinib therapy for recurrent and progressive atypical meningioma: A case report

• Liang-chen Xi,
• Fang-zheng Zhou,
• Wen-yi Lu,
• Shi-hai Wu

Affiliations

Liang-chen Xi

Department of Radiation Oncology, The Third Affiliated Hospital of Shenzhen University (Shenzhen Luohu People's Hospital), Shenzhen, Guangdong, China

Fang-zheng Zhou

Department of Radiation Oncology, The Third Affiliated Hospital of Shenzhen University (Shenzhen Luohu People's Hospital), Shenzhen, Guangdong, China

Wen-yi Lu

Department of Radiation Oncology, The Second Clinical Medical College, Shenzhen People's Hospital, Jinan University, Shenzhen, Guangdong, China

Shi-hai Wu

Corresponding author. Department of Radiation Oncology, The Second Clinical Medical College, Shenzhen People's Hospital, Jinan University, Shenzhen, Guangdong, China.; Department of Radiation Oncology, The Second Clinical Medical College, Shenzhen People's Hospital, Jinan University, Shenzhen, Guangdong, China